NASDAQ:CDMOP Avid Bioservices (CDMOP) Stock Price, News & Analysis → (Free Workshop) Advanced “bug-out bag” hacks! (From Warrior Life) (Ad) Free CDMOP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$25.06▼$25.0650-Day Range$25.03▼$25.3552-Week Range$21.00▼$31.95Volume400 shsAverage Volume11,021 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield10.49%Price TargetN/A Stock AnalysisStock Analysis Get Avid Bioservices alerts: Email Address Ad Warrior Life(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” Most citizens don’t… but according to my friend (and best-selling survival author), Jeff, even the hardcore “preppers” who cherish their bug-out bags are doing it all wrong!All the details are right here… About Avid Bioservices Stock (NASDAQ:CDMOP)Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.Read More Ad Warrior Life(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” Most citizens don’t… but according to my friend (and best-selling survival author), Jeff, even the hardcore “preppers” who cherish their bug-out bags are doing it all wrong!All the details are right here… CDMOP Stock News HeadlinesMay 23, 2024 | globenewswire.comAvid Bioservices Earns Committed Badge from EcoVadis for Sustainability PerformanceMay 16, 2024 | seekingalpha.comAvid Bioservices: A Unique Growth Story With Many Tailwinds And CatalystsMay 7, 2024 | globenewswire.comAvid Bioservices to Participate at Upcoming Investor ConferencesMay 3, 2024 | insidermonkey.comDo You Believe in the Upside Trajectory of Avid Bioservices (CDMO)?April 30, 2024 | finance.yahoo.comAvid Bioservices Inc (CDMO) Q3 2024 Earnings Call Transcript Highlights: Navigating Challenges ...April 24, 2024 | sfgate.comAvid Bioservices: Fiscal Q3 Earnings SnapshotApril 24, 2024 | globenewswire.comAvid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024April 20, 2024 | seekingalpha.comLaughing Water Capital Q1 2024 LetterMarch 20, 2024 | finanznachrichten.deAvid Bioservices, Inc: Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-QMarch 20, 2024 | globenewswire.comAvid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-QMarch 16, 2024 | ca.finance.yahoo.comCDMO Jul 2024 2.500 callMarch 16, 2024 | ca.finance.yahoo.comCDMO Dec 2024 15.000 callMarch 16, 2024 | finance.yahoo.comCDMO Apr 2024 7.500 callMarch 11, 2024 | finance.yahoo.comAvid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial ResultsMarch 9, 2024 | morningstar.comAvid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsMarch 8, 2024 | seekingalpha.comAvid Bioservices Faces Financial Strain Amid Market Challenges (Rating Downgrade)March 6, 2024 | globenewswire.comAvid Bioservices Announces Pricing of Private Placement of Convertible NotesMarch 6, 2024 | globenewswire.comAvid Bioservices Announces Proposed Private Placement of Convertible NotesMarch 6, 2024 | globenewswire.comAvid Bioservices Announces Proposed Private Placement of Convertible NotesMarch 6, 2024 | globenewswire.comAvid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024March 6, 2024 | globenewswire.comAvid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024February 22, 2024 | benzinga.comAvid Bioservices Stock (NASDAQ:CDMO), Short Interest ReportFebruary 8, 2024 | seekingalpha.comLaughing Water Capital - Avid Bioservices: Substantial Future Earnings Power, Strong Competitive PositionJanuary 30, 2024 | insidermonkey.comAvid Bioservices (CDMO) Declined in 2023January 12, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$527.5k On Avid BioservicesSee More Headlines Receive CDMOP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avid Bioservices and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:CDMOP CUSIPN/A CIK704562 Webwww.avidbio.com Phone714 508 6100FaxN/AEmployees222Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Daniel R. Hart (Age 48)Chief Financial Officer Comp: $488.87kMr. Mark R. Ziebell (Age 57)VP, Gen. Counsel & Corp. Sec. Comp: $662.28kMr. Nicholas Stewart Green (Age 56)Pres, CEO & Director Mr. Richard Richieri (Age 56)Chief Operations Officer Ms. Lorna LarsonSr. Director of HRMr. Timothy ComptonChief Commercial OfficerDr. Shelley P. M. Fussey (Age 55)VP of Intellectual Property Ms. Tracy L. KinjerskiVP of Bus. OperationsMr. Harold F. DvorakMedical & Scientific AdvisorProf. Alan J. SchroitMedical & Scientific AdvisorMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAlpha Tau MedicalNASDAQ:DRTSWApollomicsNASDAQ:APLMWArtelo BiosciencesNASDAQ:ARTLWView All Competitors CDMOP Stock Analysis - Frequently Asked Questions Is Avid Bioservices a good dividend stock? Avid Bioservices (NASDAQ:CDMOP) pays an annual dividend of $2.63 per share and currently has a dividend yield of 9.49%. CDMOP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for CDMOP. This page (NASDAQ:CDMOP) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | SponsoredBitcoin’s Biggest Year Yet2024 is set to be a historic year for Bitcoin. It’s all thanks to three major catalysts that I reveal in my...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avid Bioservices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.